secwatch.observer — SEC 8-K summary
======================================

Issuer:     NewAmsterdam Pharma Co N.V. (NAMS)
CIK:        0001936258
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0000950170-25-084663
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NewAmsterdam Pharma holds R&D Day; no material updates extracted from filing
----------------------------------------------------------------------------

- Company hosted R&D Day on June 11, 2025 in New York City with live webcast.
- Presentation furnished as Exhibit 99.1, but no specific pipeline or financial data disclosed in available text.
- No concrete numeric updates on obicetrapib trials, revenue, or guidance provided in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1936258/000095017025084663/0000950170-25-084663-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1936258/000095017025084663/nams-20250611.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-084663

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer